Exelixis (EXEL) Tops Q2 EPS by 30c
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $51.35 --0%
Revenue Growth %: +11.3%
Financial Fact:
Total other income (expense), net: 749K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +11.3%
Financial Fact:
Total other income (expense), net: 749K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.37, $0.30 better than the analyst estimate of $0.07. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $298.16 million.
GUIDANCE:
Exelixis sees FY2021 revenue of $1.3-1.4 billion, versus the consensus of $1.23 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
- Exelixis colorectal cancer trial misses one of two survival goals
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
